Next-Generation Fighter Jets?!? (Must See)
The U.S. Department of Defense is using one shocking company to develop breakthrough tech...And at less than $2... this could be the last bargain on the market.

Get the Details Here (Act Fast... a Key Announcement in December Could Send It Rocketing)

PHGE Insider Trading

Insider Ownership Percentage: 9.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $200,405.17

BiomX Insider Trading History Chart

This chart shows the insider buying and selling history at BiomX by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BiomX Share Price & Price History

Current Price: $0.27
Price Change: Price Increase of +0.02 (8.13%)
As of 12/2/2022 01:00 AM ET

This chart shows the closing price history over time for PHGE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
🚨 [Strong Buy Alert] Is this laser stock in your portfolio?
There are very few opportunities like this in today's bear market...

But our analysts identified a tiny defense company landing billions of dollars in contracts every year.
Get the name of the company here >>>

BiomX Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/4/2022Chidozie UgwumbaMajor ShareholderSell1,501$0.38$570.382,997,025View SEC Filing Icon  
11/2/2022Chidozie UgwumbaMajor ShareholderSell2,416$0.36$869.763,000,526View SEC Filing Icon  
10/31/2022Chidozie UgwumbaMajor ShareholderSell3,300$0.37$1,221.003,004,242View SEC Filing Icon  
10/28/2022Chidozie UgwumbaMajor ShareholderSell1,526$0.36$549.363,007,542View SEC Filing Icon  
10/26/2022Chidozie UgwumbaMajor ShareholderSell12,500$0.35$4,375.003,010,573View SEC Filing Icon  
10/24/2022Chidozie UgwumbaMajor ShareholderSell5,900$0.35$2,065.003,026,145View SEC Filing Icon  
10/21/2022Chidozie UgwumbaMajor ShareholderSell5,400$0.37$1,998.003,032,045View SEC Filing Icon  
10/19/2022Chidozie UgwumbaMajor ShareholderSell4,501$0.37$1,665.373,044,081View SEC Filing Icon  
10/17/2022Chidozie UgwumbaMajor ShareholderSell8,098$0.34$2,753.323,063,882View SEC Filing Icon  
10/14/2022Chidozie UgwumbaMajor ShareholderSell3,420$0.33$1,128.603,071,980View SEC Filing Icon  
10/12/2022Chidozie UgwumbaMajor ShareholderSell9,700$0.33$3,201.003,086,714View SEC Filing Icon  
10/10/2022Chidozie UgwumbaMajor ShareholderSell10,043$0.33$3,314.193,102,402View SEC Filing Icon  
10/7/2022Chidozie UgwumbaMajor ShareholderSell24,708$0.36$8,894.883,112,445View SEC Filing Icon  
10/5/2022Chidozie UgwumbaMajor ShareholderSell46,785$0.43$20,117.553,162,251View SEC Filing Icon  
10/3/2022Chidozie UgwumbaMajor ShareholderSell15,022$0.33$4,957.263,228,236View SEC Filing Icon  
9/30/2022Chidozie UgwumbaMajor ShareholderSell8,662$0.36$3,118.323,243,258View SEC Filing Icon  
9/28/2022Chidozie UgwumbaMajor ShareholderSell15,649$0.33$5,164.173,255,220View SEC Filing Icon  
9/26/2022Chidozie UgwumbaMajor ShareholderSell17,528$0.35$6,134.803,275,735View SEC Filing Icon  
9/23/2022Chidozie UgwumbaMajor ShareholderSell5,306$0.37$1,963.223,293,263View SEC Filing Icon  
9/21/2022Chidozie UgwumbaMajor ShareholderSell5,574$0.43$2,396.823,315,957View SEC Filing Icon  
9/19/2022Chidozie UgwumbaMajor ShareholderSell13,870$0.48$6,657.603,332,157View SEC Filing Icon  
9/16/2022Chidozie UgwumbaMajor ShareholderSell3,200$0.51$1,632.003,346,027View SEC Filing Icon  
9/14/2022Chidozie UgwumbaMajor ShareholderSell2,301$0.52$1,196.523,353,127View SEC Filing Icon  
9/12/2022Chidozie UgwumbaMajor ShareholderSell1,700$0.54$918.003,357,629View SEC Filing Icon  
9/8/2022Chidozie UgwumbaMajor ShareholderSell4,592$0.52$2,387.843,372,548View SEC Filing Icon  
9/6/2022Chidozie UgwumbaMajor ShareholderSell6,403$0.55$3,521.653,385,986View SEC Filing Icon  
9/2/2022Chidozie UgwumbaMajor ShareholderSell2,001$0.55$1,100.553,392,389View SEC Filing Icon  
8/31/2022Chidozie UgwumbaMajor ShareholderSell4,540$0.55$2,497.003,402,687View SEC Filing Icon  
8/29/2022Chidozie UgwumbaMajor ShareholderSell11,533$0.57$6,573.813,420,714View SEC Filing Icon  
8/26/2022Chidozie UgwumbaMajor ShareholderSell60,628$0.62$37,589.363,432,247View SEC Filing Icon  
8/24/2022Chidozie UgwumbaMajor ShareholderSell8,665$0.65$5,632.253,519,820View SEC Filing Icon  
8/22/2022Chidozie UgwumbaMajor ShareholderSell5,000$0.66$3,300.003,534,385View SEC Filing Icon  
8/19/2022Chidozie UgwumbaMajor ShareholderSell14,600$0.64$9,344.003,539,385View SEC Filing Icon  
8/17/2022Chidozie UgwumbaMajor ShareholderSell21,335$0.69$14,721.153,561,749View SEC Filing Icon  
8/15/2022Chidozie UgwumbaMajor ShareholderSell7,200$0.75$5,400.003,591,647View SEC Filing Icon  
8/12/2022Chidozie UgwumbaMajor ShareholderSell11,406$0.73$8,326.383,598,847View SEC Filing Icon  
8/10/2022Chidozie UgwumbaMajor ShareholderSell17,769$0.74$13,149.063,620,077View SEC Filing Icon  
7/28/2021Jonathan Eitan SolomonCEOBuy25,000$4.00$100,000.0025,000View SEC Filing Icon  
7/28/2021Lynne Marie SullivanDirectorBuy12,500$4.00$50,000.00View SEC Filing Icon  
7/28/2021Marina WolfsonSVPBuy3,750$4.00$15,000.003,750View SEC Filing Icon  
See Full Table
🚨 [Strong Buy Alert] Is this laser stock in your portfolio?
There are very few opportunities like this in today's bear market...

But our analysts identified a tiny defense company landing billions of dollars in contracts every year.
Get the name of the company here >>>

SEC Filings (Institutional Ownership Changes) for BiomX (NYSEMKT:PHGE)

25.54% of BiomX stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PHGE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BiomX Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/3/2022Royce & Associates LP158,655$54K0.0%-51.7%0.529%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC78,933$58K0.0%-18.9%0.263%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC42,200$31K0.0%+76.6%0.142%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC24,984$48K0.0%N/A0.084%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC23,900$46K0.0%-68.7%0.080%Search for SEC Filing on Google Icon
5/5/2022Royce & Associates LP320,655$0.62M0.0%+200.5%1.077%Search for SEC Filing on Google Icon
2/7/2022Royce & Associates LP106,696$0.17M0.0%-52.7%0.373%Search for SEC Filing on Google Icon
11/12/2021Johnson & Johnson2,133,402$6.53M0.6%N/A7.568%Search for SEC Filing on Google Icon
10/26/2021Taylor Wealth Management Partners40,098$91K0.0%-44.3%0.142%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC427,702$2.34M0.0%-5.9%1.758%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC104,000$0.57M0.0%-15.4%0.427%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC454,377$3.24M0.0%-1.2%1.954%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC25,365$0.18M0.0%N/A0.109%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC36,200$0.26M0.0%N/A0.156%Search for SEC Filing on Google Icon
5/10/2021Royce & Associates LP359,000$2.56M0.0%N/A1.544%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BiomX logo
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease; and BX003, an orally administered phage cocktail, which is in Phase 1b/2a that targets a bacterial target present in the gut of IBD and PSC patients. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Read More on BiomX

Today's Range

Now: $0.27
Low: $0.25
High: $0.27

50 Day Range

MA: $0.33
Low: $0.24
High: $0.45

52 Week Range

Now: $0.27


53,974 shs

Average Volume

50,950 shs

Market Capitalization

$7.97 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of BiomX?

BiomX's top insider shareholders include:
  1. Chidozie Ugwumba (Major Shareholder)
  2. Jonathan Eitan Solomon (CEO)
  3. Marina Wolfson (SVP)
  4. Lynne Marie Sullivan (Director)
Learn More about top insider investors at BiomX.

Who are the major institutional investors of BiomX?

BiomX's top institutional investors include:
  1. Royce & Associates LP — 0.53%
Learn More about top institutional investors of BiomX stock.

Which institutional investors are selling BiomX stock?

During the last quarter, PHGE stock was sold by these institutional investors:
  1. Royce & Associates LP
Our Top 5 Microcap Stocks
Microcap stocks tend to be an under-researched area… Which increases the odds of discovering attractive investment opportunities.

Just like these 5 which appear to be in an excellent position to see a surge in share price.
>>> See All 5 Here